Drug Pipeline

Oral paclitaxel Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
1
Phase 3
3
Top Sponsors
Active Studies by Phase
Phase 2/3
1
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT03315364 Oral Paclitaxel Trial In Recurrent and Metastatic Breast Cancer As 1st Line Therapy Recurrent or Metastatic Breast Cancer Active, Not Recruiting
Phase 2
NCT06326346 GIST Oral Paclitaxel(Liporaxel) Gastrointestinal Stromal Tumors Recruiting
NCT07441486 A Single-arm, Prospective, Phase II Clinical Study of the Combination of Entinostat and… Breast Cancer Not Yet Recruiting
Sponsors Running Oral paclitaxel Trials
Daehwa Pharmaceutical Co., Ltd. (1) Asan Medical Center (1) Tianjin Medical University Cancer Institute and Hospital (1)
Disease Areas
Breast Cancer (2)
Get alerts when Oral paclitaxel trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free